Lexicon Pharmaceuticals Inc

LXRXNASDAQ · USD
1.80USD+0.01 (-3.50%)
149

Lexicon Pharmaceuticals Inc (LXRX) Covered Calls

As of September 25, 2026, LXRX has 6 covered call opportunities in the coming three months. Return ranges from 13.9 to 180.6% until expiration. Annualized return ranges from 40.0 to 324.6%. The nearest expiration is October 16, 2026. Maximum potential profit is $325.

Read more

Running LXRX covered calls helps you generate consistent income from Lexicon Pharmaceuticals Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Lexicon Pharmaceuticals Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best LXRX covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if LXRX stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling LXRX covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Lexicon Pharmaceuticals Inc covered call is worth writing.

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas.

Income-focused investors, long-term LXRX holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling LXRX covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Lexicon Pharmaceuticals Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile21.43% Subdued
  • Market cap (M$)799
  • 52 weeks high-32.84%
  • 52 weeks low63.64%
  • Analyst recommendationBuy
    1.80
  • Target price$3.86
    114.44% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-05
  • P/E—
  • Future P/E—
  • EPS (ttm)-0.15
  • EPS growth next 5 years12.33%

As of September 25, 2026

2027-04-162035.00177.780.050.25325.00180.56324.64-2.78+0.2400.20
2026-10-16212.0011.110.050.1025.0013.89241.40-2.78+0.341,7340.05
2027-01-151122.5038.890.150.2085.0047.22153.89-8.33+0.363,6780.05
2026-11-20562.0011.110.200.2540.0022.22144.84-11.11+0.49100.05
2027-01-151122.0011.110.250.4045.0025.0081.47-13.89+0.547930.15
2027-04-162032.0011.110.200.5040.0022.2239.96-11.11+0.56430.30

As of September 25, 2026

Sell covered calls with the data behind you

Find the best LXRX covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial